Ultomiris: Can drug innovation be too expensive?
ADOBE
Alexion's blockbuster drug Soliris will soon go off patent. It's new drug, Ultomiris, does the same task. Should this innovation get full patent protection?
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario